发明名称 LYOPHILIZED PRODUCTS OF ETANERCEPT
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition suitable for lyophilized products which are excellent in storage stability, the composition containing a polypeptide (TNFR-Fc) in which the extracellular ligand-binding moiety of a human p75 tumor necrosis factor receptor fuses to the Fc region of human IgG1.SOLUTION: The invention relates to a lyophilized composition containing a polypeptide in which the extracellular ligand-binding moiety of a human p75 tumor necrosis factor receptor fuses to the Fc region of human IgG1, the composition containing (1) sucrose and/or trehalose, etc., (2) methionine and/or histidine, and (3) 100 mM or less of a pharmaceutically acceptable salt; and to a production method thereof.SELECTED DRAWING: None
申请公布号 JP2016088897(A) 申请公布日期 2016.05.23
申请号 JP20140226526 申请日期 2014.11.06
申请人 MOCHIDA PHARMACEUT CO LTD 发明人 SEGAWA MASASHI;KOJIMA SHOTA
分类号 A61K38/00;A61K9/08;A61K9/19;A61K47/20;A61K47/22;A61K47/26;A61P1/00;A61P1/16;A61P11/00;A61P11/06;A61P15/02;A61P17/06;A61P19/00;A61P19/02;A61P25/28;A61P29/00;A61P35/00;A61P37/06 主分类号 A61K38/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利